Clinical Trials Update: June 2, 2009

June 2, 2009 RSS Feed Print

High Cholesterol
Renal Impairment
Insomnia
Diabetes Mellitus, Type 2
Osteoarthritis
Alzheimer's Disease

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com and CenterWatch:

High Cholesterol

This study seeks people who have high cholesterol. Participants will receive all study related care and investigational medication at no cost, and may qualify for time and travel compensation.

The research site is in Chicago, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.

-----

Renal Impairment

This study will compare healthy people with those who have mild, moderate and severe renal impairment.

The research site is in Indianapolis, Ind.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/kidney_disease.aspx.

-----

Insomnia

This study is evaluating the safety and efficacy of an investigational medication for sleep-maintenance insomnia.

The research site is in Glendale, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/insomnia.aspx.

-----

Diabetes Mellitus, Type 2

If you are diabetic, have been treated with pioglitazone (Actos) at a dose of 30 mg. or 45 mg. per day for at least three months, and have a HgbA1c between 7.0 percent and 10.5 percent, you may qualify for this study.

The research site is in Colorado Springs, Colo.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=603.

-----

Osteoarthritis

If you have painful osteoarthritis of the hip or knee and are taking naproxen or celecoxib, you may qualify for this study.

The research site is in Dallas, Texas.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=109.

-----

Alzheimer's Disease

If you or a loved one are aged 50 to 90, have mild-to-moderate Alzheimer's disease, and are being treated with Donepezil, you or the loved one may qualify for this study.

The research site is in Ocala, Fla.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=11.

-----